Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-20-051061
Filing Date
2020-09-17
Accepted
2020-09-17 20:32:33
Documents
2
Period of Report
2020-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 9921
2 POA DOCUMENT poa.txt EX-24.3_937722 2097
  Complete submission text file 0001209191-20-051061.txt   13512
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address
Litton Mark James (Reporting) CIK: 0001604834 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39503 | Film No.: 201182478

Mailing Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141
Business Address 4000 MASON ROAD, SUITE 300 BOX 352141 SEATTLE WA 981952141 5095927191
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)